Abstract
Effective treatment to improve outcome after the onset of acute ischemic stroke continues to be elusive. Interest in thrombolytic therapy as a potential treatment for stroke has undergone a revival coincident with the development of newer agents, such as human recombinant tissue-type plasminogen activator (rt-PA), and better appreciation for the need for rapid treatment within the first minutes to hours after the onset of symptoms [1].
The NINDS t-PA Stroke Trial Investigators are listed in the Appendix, and correspondence should be addressed to: E. Clarke Haley, Jr., Box 394, Dept. of Neurology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Levine SR, Brott TG (1992) Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis 34: 235–262
del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86
Brott TG, Haley EC, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marier JR (1992) Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23: 632–640
Haley EC, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, Torner JC, Marler JR (1992) Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke 23: 641–645
Von Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23: 646–652
Mori E, Yoneda Y, Tabuchi M. Yoshida T, Ohkawa S. Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976–982
Haley EC, Brott TG, Sheppard GL, Barsan W. Broderick J, Marler JR, Kongable GL, Spilker J, Massey S, Hansen CA, Torner JC, for the TPA Bridging Study Group (1993) Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 24: 1000–1004
Brott TG, Adams HP. Olinger CP. Marler JR, Barsan WG. Biller J, Spilker J, Holleran R. Eberle R, Hertzberg V. Rorick M, Moomaw CJ, Walker M (1989) Measurement of acute cerebral infarction: a clinical examination scale. Stroke 20: 864–870
Lefkopoulou M. Ryan L (1989) Global tests for multiple binary outcomes. Biometrics 4: 975–988
Author information
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Tokyo
About this paper
Cite this paper
The NINDS t-PA Stroke Trial Investigators. (1995). The NINDS t-PA Stroke Trial: Progress Report. In: Yamaguchi, T., Mori, E., Minematsu, K., del Zoppo, G.J. (eds) Thrombolytic Therapy in Acute Ischemic Stroke III. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68459-6_22
Download citation
DOI: https://doi.org/10.1007/978-4-431-68459-6_22
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70139-2
Online ISBN: 978-4-431-68459-6
eBook Packages: Springer Book Archive